{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T19:53:38Z","timestamp":1760644418225,"version":"3.41.2"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1023\/a:1011800919981","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T06:26:45Z","timestamp":1040624805000},"page":"463-470","source":"Crossref","is-referenced-by-count":21,"title":["Immunolocalization of matrix metalloproteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma"],"prefix":"10.1007","volume":"18","author":[{"given":"\u0160\u00e1rka","family":"Lhot\u00e1k","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leelamma J.","family":"Elavathil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sne\u017eana","family":"Vukmirovi\u0107-Popovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilhelmina C.M.","family":"Duivenvoorden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G.","family":"Tozer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurmit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"351810_CR1","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I","volume":"80","author":"GR. Mundy","year":"1997","unstructured":"Mundy GR. Mechanisms of bone metastasis. Cancer 1997; 80: 1546\u201356.","journal-title":"Cancer"},{"key":"351810_CR2","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1084\/jem.188.5.997","volume":"188","author":"K Fuller","year":"1998","unstructured":"Fuller K, Wong B, Fox S et al. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 1998; 188: 997\u20131001.","journal-title":"J Exp Med"},{"key":"351810_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/8756-3282(94)90703-X","volume":"15","author":"T Taube","year":"1994","unstructured":"Taube T, Elomaa I, Blomqvist C et al. Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone 1994; 15: 161\u20136.","journal-title":"Bone"},{"key":"351810_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/BF00710766","volume":"409","author":"H-A Kulenkampff","year":"1986","unstructured":"Kulenkampff H-A, Dreyer T, Kersjes W et al. Histomorphometric analysis of osteoclastic bone resorption in metastatic bone disease from various primary malignomas. Virchows Arch A Pathol Anat Histopathol 1986; 409: 817\u201328.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"351810_CR5","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1572::AID-CNCR7>3.0.CO;2-M","volume":"80","author":"TA. Guise","year":"1997","unstructured":"Guise TA. Parathyroid hormone-related protein and bone metastases. Cancer 1997; 80: 1572\u201380.","journal-title":"Cancer"},{"key":"351810_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/00003086-200004000-00013","volume":"373","author":"DR Clohisy","year":"2000","unstructured":"Clohisy DR, Perkins SL, Ramnaraine MLR. Review of cellular mechanisms of tumor osteolysis. Clin Orthop Related Res 2000; 373: 104\u201314.","journal-title":"Clin Orthop Related Res"},{"key":"351810_CR7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/07357900009012171","volume":"18","author":"LJ Miller","year":"2000","unstructured":"Miller LJ, Kurtzman SH, Anderson K et al. Interleukin-1 family expression in human breast cancer: Interleukin-1 receptor antagonist. Cancer Invest 2000; 18: 293\u2013302.","journal-title":"Cancer Invest"},{"key":"351810_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0304-3835(97)00542-9","volume":"127","author":"M Lacroix","year":"1998","unstructured":"Lacroix M, Siwek B, Marie PJ et al. Production and regulation of interleukin-11 by breast cancer cells. Cancer Lett 1998; 127: 29\u201335.","journal-title":"Cancer Lett"},{"key":"351810_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/sj.bjc.6690394","volume":"80","author":"G Fontanini","year":"1999","unstructured":"Fontanini G, Campani D, Roncella M et al. Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma. Br J Cancer 1999; 80: 579\u201384.","journal-title":"Br J Cancer"},{"key":"351810_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1006\/excr.1998.4320","volume":"247","author":"E Jimi","year":"1999","unstructured":"Jimi E, Nakamura I, Duong LT et al. Interleukin-1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts\/stromal cells. Exp Cell Res 1999; 247: 84\u201393.","journal-title":"Exp Cell Res"},{"key":"351810_CR11","doi-asserted-by":"publisher","first-page":"8799","DOI":"10.1074\/jbc.273.15.8799","volume":"273","author":"E Jimi","year":"1998","unstructured":"Jimi E, Nakamura I, Ikebe T et al. Activation of NF-kB is involved in the survival of osteoclasts promoted by interleukin-1. J Biol Chem 1998; 273: 8799\u2013805.","journal-title":"J Biol Chem"},{"key":"351810_CR12","doi-asserted-by":"publisher","first-page":"12511","DOI":"10.1074\/jbc.271.21.12511","volume":"271","author":"FH Drake","year":"1996","unstructured":"Drake FH, Dodds RA, James IE et al. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 1996; 271: 12511\u20136.","journal-title":"J Biol Chem"},{"key":"351810_CR13","doi-asserted-by":"publisher","first-page":"12517","DOI":"10.1074\/jbc.271.21.12517","volume":"271","author":"MJ Bossard","year":"1996","unstructured":"Bossard MJ, Tomaszek TA, Thompson SK et al. Proteolytic activity of human osteoclast cathepsin. J Biol Chem 1996; 271: 12517\u201324.","journal-title":"J Biol Chem"},{"key":"351810_CR14","first-page":"1","volume":"213","author":"WC Powell","year":"1996","unstructured":"Powell WC, Matrisian LM. Complex roles of matrix metalloproteinases in tumor progression. Curr Top Microbiol Immunol 1996; 213: 1\u201321.","journal-title":"Curr Top Microbiol Immunol"},{"key":"351810_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1749-6632.1999.tb07677.x","volume":"878","author":"L Blavier","year":"1999","unstructured":"Blavier L, Henriet P, Imren S et al. Tissue inhibitors of matrix metalloproteinases in cancer. Ann NY Acad Sci 1999; 878: 108\u201319.","journal-title":"Ann NY Acad Sci"},{"key":"351810_CR16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj3340345","volume":"334","author":"K Lehti","year":"1998","unstructured":"Lehti K, Lohi J, Valtanen H et al. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J 1998; 334: 345\u201353.","journal-title":"Biochem J"},{"key":"351810_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/jcp.1041500202","volume":"150","author":"V Everts","year":"1992","unstructured":"Everts V, Delaiss\u00e9 JM, Korper W et al. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cystein-proteinases and matrix metalloproteinases. J Cell Physiol 1992; 150: 221\u201331.","journal-title":"J Cell Physiol"},{"key":"351810_CR18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1242\/jcs.76.1.155","volume":"76","author":"TJ Chambers","year":"1985","unstructured":"Chambers TJ, Fuller K. Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact. J Cell Sci 1985; 76: 155\u201365.","journal-title":"J Cell Sci"},{"key":"351810_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0092-8674(00)81169-1","volume":"93","author":"TH Vu","year":"1998","unstructured":"Vu TH, Shipley JM, Bergers G et al. MMP-9\/Gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998; 93: 411\u201322.","journal-title":"Cell"},{"key":"351810_CR20","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1083\/jcb.151.4.879","volume":"151","author":"MT Engsig","year":"2000","unstructured":"Engsig MT, Chen Q-J, Vu TH et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 2000; 151: 878\u201389.","journal-title":"J Cell Biol"},{"key":"351810_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0092-8674(00)80064-1","volume":"99","author":"K Holmbeck","year":"1999","unstructured":"Holmbeck K, Bianco P, Caterina J et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999; 99: 81\u201392.","journal-title":"Cell"},{"key":"351810_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1046\/j.1524-475X.1999.00423.x","volume":"7","author":"WC. Parks","year":"1999","unstructured":"Parks WC. Matrix metalloproteinases in repair. Wound Rep Reg 1999; 7: 423\u201332.","journal-title":"Wound Rep Reg"},{"key":"351810_CR23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/002215549704500508","volume":"45","author":"M Polette","year":"1997","unstructured":"Polette M, Gilles C, Marchand V et al. Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers. J Histochem Cytochem 1997; 45: 703\u20139.","journal-title":"J Histochem Cytochem"},{"key":"351810_CR24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/bjc.1995.200","volume":"71","author":"A Ito","year":"1995","unstructured":"Ito A, Nakajima S, Sasaguri Y et al. Co-culture of human breast adenocarcinoma MCF-7 cells with human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br J Cancer 1995; 71: 1039\u201345.","journal-title":"Br J Cancer"},{"key":"351810_CR25","first-page":"3154","volume":"53","author":"H Kataoka","year":"1993","unstructured":"Kataoka H, DeCastro R, Zucker R et al. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res 1993; 53: 3154\u20138.","journal-title":"Cancer Res"},{"key":"351810_CR26","first-page":"115","volume":"2","author":"WCM Duivenvoorden","year":"2000","unstructured":"Duivenvoorden WCM, Lhotak S, Lee F et al. Bone metastasis in human breast and prostate cancer: Involvement of matrix metalloproteinases. Recent Res Devel Cancer 2000; 2: 115\u201341.","journal-title":"Recent Res Devel Cancer"},{"key":"351810_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/8756-3282(88)90029-4","volume":"9","author":"AM. Parfitt","year":"1988","unstructured":"Parfitt AM. Bone histomorphometry: Standardization of nomenclature, symbols and units (summary of proposed system). Bone 1988; 9: 67\u20139.","journal-title":"Bone"},{"key":"351810_CR28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/bjc.1994.336","volume":"70","author":"T Baker","year":"1994","unstructured":"Baker T, Tickle S, Wasan H et al. Serum metalloproteinases and their inhibitors: markers for malignant potential. Br J Cancer 1994; 70: 506\u201312.","journal-title":"Br J Cancer"},{"key":"351810_CR29","first-page":"1343","volume":"12","author":"MJ Duffy","year":"1998","unstructured":"Duffy MJ, McCarthy K. Matrix metalloproteinases in cancer: Prognostic marker and targets for therapy. Int J Oncol 1998; 12: 1343\u20138.","journal-title":"Int J Oncol"},{"key":"351810_CR30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/10428190009089428","volume":"37","author":"T Kelly","year":"2000","unstructured":"Kelly T, B\u00f8rset M, Abe E et al. Matrix metalloproteinases in multiple myeloma. Leuk Lymph 2000; 37: 273\u201381.","journal-title":"Leuk Lymph"},{"key":"351810_CR31","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/(SICI)1097-0215(20000315)85:6<801::AID-IJC11>3.0.CO;2-C","volume":"85","author":"M Lein","year":"2000","unstructured":"Lein M, Jung K, Laube C et al. Matrix metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma. Int J Cancer 2000; 85: 801\u20134.","journal-title":"Int J Cancer"},{"key":"351810_CR32","first-page":"5365","volume":"53","author":"B Davies","year":"1993","unstructured":"Davies B, Waxman J, Wasan H et al. Levels of matrix metalloproteinase in bladder cancer correlate with tumor grade and invasion. Cancer Res 1993; 53: 5365\u20139.","journal-title":"Cancer Res"},{"key":"351810_CR33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1101\/gad.13.1.35","volume":"13","author":"Q Yu","year":"1999","unstructured":"Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 1999; 13: 35\u201348.","journal-title":"Genes Dev"},{"key":"351810_CR34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1242\/jcs.103.4.1093","volume":"103","author":"MC Meikle","year":"1992","unstructured":"Meikle MC, Bord S, Hembry RM et al. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. J Cell Sci 1992; 103: 1093\u20139.","journal-title":"J Cell Sci"},{"key":"351810_CR35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0934-8832(11)80080-6","volume":"12","author":"JA Lorenzo","year":"1992","unstructured":"Lorenzo JA, Pilbeam CC, Kalinowski JF et al. Production of both 92-and 72-kDa gelatinases by bone cells. Matrix 1992; 12: 282\u201390.","journal-title":"Matrix"},{"key":"351810_CR36","first-page":"311","volume":"72","author":"Y Okada","year":"1995","unstructured":"Okada Y, Naka K, Kawamura K et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase\/type IV collagenase=gelatinase B) in osteoclasts: Implications for bone resorption. Lab Invest 1995; 72: 311\u201321.","journal-title":"Lab Invest"},{"key":"351810_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S8756-3282(98)00174-4","volume":"24","author":"S Bord","year":"1999","unstructured":"Bord S, Horner A, Beeton CA et al. Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human bone. Bone 1999; 24: 229\u201335.","journal-title":"Bone"},{"key":"351810_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/8756-3282(95)00219-4","volume":"17","author":"MC Meikle","year":"1995","unstructured":"Meikle MC, Bord S, Hembry RM et al. The synthesis of collagenase, gelatinase-A (72 kDa) and-B (95 kDa), and TIMP-1 and-2 by human osteoblasts from normal and arthritic bone. Bone 1995; 17: 255\u201360.","journal-title":"Bone"},{"key":"351810_CR39","first-page":"701","volume":"52","author":"YA DeClerck","year":"1992","unstructured":"DeClerck YA, Perez N, Shimada H et al. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992; 52: 701\u20138.","journal-title":"Cancer Res"},{"key":"351810_CR40","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jnci\/83.11.775","volume":"83","author":"A Albini","year":"1991","unstructured":"Albini A, Melchiori A, Santi L et al. Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 1991; 83: 775\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"351810_CR41","first-page":"220","volume":"7","author":"WF Grigioni","year":"1994","unstructured":"Grigioni WF, D'Errico A, Fortunato C et al. Prognosis of gastric carcinoma revealed by the interactions between tumor cells and basement membrane. Mod Pathol 1994; 7: 220\u20135.","journal-title":"Mod Pathol"},{"key":"351810_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/1523-1747.ep12342979","volume":"106","author":"SN Wagner","year":"1996","unstructured":"Wagner SN, Ockenfels HM, Wagner C et al. Differential expression of tissue inhibitor of metalloproteinase-2 by cutaneous squamous and basal cell carcinomas. J Invest Dermatol 1996; 106: 321\u20136.","journal-title":"J Invest Dermatol"},{"key":"351810_CR43","first-page":"1623","volume":"3","author":"AH Ree","year":"1997","unstructured":"Ree AH, Fl\u00f8renes VA, Berg JP et al. High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases. Clin Cancer Res 1997; 3: 1623\u20138.","journal-title":"Clin Cancer Res"},{"key":"351810_CR44","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ijc.2910590308","volume":"59","author":"DW Visscher","year":"1994","unstructured":"Visscher DW, H\u00f6yhty\u00e4 M, Ottosen SK et al. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer 1994; 59: 339\u201344.","journal-title":"Int J Cancer"},{"key":"351810_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0167-4889(93)90159-M","volume":"1177","author":"PA Hill","year":"1993","unstructured":"Hill PA, Reynolds JJ, Meikle MC. Inhibition of stimulated bone resorption in vitro by TIMP-1 and TIMP-2. Biochim Biophys Acta 1993; 1177: 71\u20134.","journal-title":"Biochim Biophys Acta"},{"key":"351810_CR46","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1172\/JCI119435","volume":"99","author":"T Yoneda","year":"1997","unstructured":"Yoneda T, Sasaki A, Dunstan C et al. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate Ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest 1997; 99: 2509\u201317.","journal-title":"J Clin Invest"},{"key":"351810_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s007740050091","volume":"17","author":"T Shibutani","year":"1999","unstructured":"Shibutani T, Yamashita K, Aoki T et al. Tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) stimulate osteoclastic bone resorption. J Bone Miner Metab 1999; 17: 245\u201351.","journal-title":"J Bone Miner Metab"},{"key":"351810_CR48","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1242\/jcs.107.9.2373","volume":"107","author":"T Hayakawa","year":"1994","unstructured":"Hayakawa T, Yamashita K, Ohuchi E et al. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci 1994; 107: 2373\u20139.","journal-title":"J Cell Sci"},{"key":"351810_CR49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S8756-3282(99)00157-X","volume":"25","author":"H Yamagiwa","year":"1999","unstructured":"Yamagiwa H, Tokunaga K, Hayami T et al. Expression of metalloproteinase-13 (Collagenase-3) is induced during fracture healing in mice. Bone 1999; 25: 197\u2013203.","journal-title":"Bone"},{"key":"351810_CR50","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1200\/JCO.2000.18.1.178","volume":"18","author":"EK Rowinsky","year":"2000","unstructured":"Rowinsky EK, Humphrey R, Hammond LA et al. Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies. J Clin Oncol 2000; 18: 178\u201386.","journal-title":"J Clin Oncol"},{"key":"351810_CR51","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s005340050063","volume":"5","author":"SR. Bramhall","year":"1998","unstructured":"Bramhall SR. Stromal degradation by the malignant epithelium in pancreatic cancer and the therapeutic potential of proteolytic inhibition. J Hepatobiliary Pacreat Surg 1998; 5: 392\u2013401.","journal-title":"J Hepatobiliary Pacreat Surg"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011800919981.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1011800919981\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011800919981.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T22:08:44Z","timestamp":1752358124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1011800919981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["351810"],"URL":"https:\/\/doi.org\/10.1023\/a:1011800919981","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"type":"print","value":"0262-0898"},{"type":"electronic","value":"1573-7276"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}